HC Andersen Capital will be hosting a webinar on Zerion Pharma where our CEO Ole Wiborg and CFO Jakob Dynnes Hansen will introduce the company.

It is an online event taking place on 08 February 2023 11:00 - 11:30.  

 Register by clicking on the link: https://hcandersencapital.dk/event/zerion-pharma-company-introduction/ 

ZERION aims to make a real difference in health care with its Dispersome® technology in relation to the formulation of new and existing drugs. Poor drug solubility is one of the main reasons for drug development failure. ZERION has a solution - Dispersome® - a technology that increases the chance of success for new drug development, allows for improvement of existing drugs enabling more new drugs to reach the market, and leads to improved treatment of patients as well as reduced toxic waste. The Dispersome® technology makes it possible to reduce the number of active drugs by up to 75%.